Lufkin, J.
631  Ergebnisse:
Personensuche X
?
1

Concordance of baseline pain measures (across two reporting..:

Conaghan, P.G. ; Ross, E. ; Kivitz, A....
Osteoarthritis and Cartilage.  28 (2020)  - p. S492-S493 , 2020
 
?
3

Repeat administration of triamcinolone acetonide extended-r..:

Gomoll, A. ; Spitzer, A. ; Richmond, J.C....
Osteoarthritis and Cartilage.  27 (2019)  - p. S505-S506 , 2019
 
?
4

Safety and systemic exposure of triamcinolone acetonide fol..:

Kivitz, A. ; Mehra, P. ; Hanson, P....
Osteoarthritis and Cartilage.  27 (2019)  - p. S504-S505 , 2019
 
?
5

Triamcinolone acetonide extended-release injectable suspens..:

Katz, N.P. ; Conaghan, P.G. ; Kraus, V.B....
Osteoarthritis and Cartilage.  26 (2018)  - p. S232-S233 , 2018
 
?
 
?
 
?
8

Assessment of the safety of repeat administration of triamc..:

Spitzer, A. ; Richmond, J. ; Gomoll, A....
Osteoarthritis and Cartilage.  26 (2018)  - p. S251-S252 , 2018
 
?
 
?
10

An intra-articular, extended release formulation of triamci..:

Conaghan, P. ; Strand, V. ; Hunter, D....
Osteoarthritis and Cartilage.  25 (2017)  - p. S432-S433 , 2017
 
?
11

Sustained and profound analgesic benefits in people with os..:

Conaghan, P.G. ; Cohen, S. ; Jordan, J....
Osteoarthritis and Cartilage.  24 (2016)  - p. S49-S50 , 2016
 
?
12

Prolonged joint residency of triamcinolone acetonide after ..:

Bodick, N. ; Lufkin, J. ; Willwerth, C....
Osteoarthritis and Cartilage.  23 (2015)  - p. A360-A361 , 2015
 
?
13

Safety and efficacy of FX006 in patients with osteoarthriti..:

Bodick, N. ; Lufkin, J. ; Willwerth, C....
Osteoarthritis and Cartilage.  22 (2014)  - p. S376-S377 , 2014
 
?
14

FX006 prolongs the residency of triamcinolone acetonide in ..:

Bodick, N. ; Lufkin, J. ; Willwerth, C....
Osteoarthritis and Cartilage.  21 (2013)  - p. S144-S145 , 2013
 
?
15

How to write and publish engineering papers and reports:

Lufkin, J.
Proceedings of the IEEE.  71 (1983)  10 - p. 1231-1232 , 1983
 
1-15